After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for ADMA Biologics Inc. (ADMA) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0199, or 0.51%, to $3.9299. The ADMA Biologics Inc. has recorded 19,918 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update.
ADMA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $3.91 and fluctuated between $3.9400 as its day high and $3.8150 as its day low. The current market capitalization of ADMA Biologics Inc. is $870.37M. A total of 2.16 million shares were traded on the day, compared to an average of 2.22M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ADMA has seen 12 BUY and 9 SELL insider trades, representing the acquisition of 2,909,721 and the disposition of 3,406,618 shares. Over the last 12 months, there were 21 BUYs and 23 SELLs from insiders. Insiders purchased 3,758,809 shares during that period but sold 3,977,017.
In the most recent transaction, Grossman Jerrold B bought 130,000 shares of ADMA for 3.71 per share on Aug 30. After the transaction, the Director now owns 443,265 company shares. In a previous transaction on Aug 24, KWON YOUNG bought 25,000 shares at 3.90 per share. ADMA shares that Director owns now total 277,401.
Among the insiders who sold shares, Fong Bryant disposed of 1,433,304 shares on Aug 22 at a per-share price of $3.87. This resulted in the Director holding 0 shares of ADMA after the transaction. In another insider transaction, Grossman Adam S sold 250,000 shares at $4.15 per share on Aug 18. Company shares held by the President and CEO now total 2,273,085.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ADMA in the last 3 months, the mean price target is $6.00 with high estimates of $7.00 and low estimates of $5.00. In terms of 52-week highs and lows, ADMA has a high of $4.65 and a low of $2.24.
As of this writing, ADMA has an earnings estimate of -$0.01 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0 per share and a lower estimate of -$0.01. The company reported an EPS of -$0.03 in the last quarter, which was 25.00% higher than expectations of -$0.04.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ADMA’s latest balance sheet shows that the firm has $51.09M in Cash & Short Term Investments as of fiscal 2021. There were $102.92M in debt and $30.38M in liabilities at the time. Its Book Value Per Share was $0.66, while its Total Shareholder’s Equity was $141.17M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADMA is Buy with a score of 5.00.